Changes in microbiome predict risk for sexually transmitted disease
Reports and Proceedings
Updates every hour. Last Updated: 5-May-2025 11:09 ET (5-May-2025 15:09 GMT/UTC)
Women who develop bacterial vaginosis (BV) often later acquire chlamydia, a common and potentially serious sexually transmitted bacterial infection. Now, researchers at Albert Einstein College of Medicine, Roswell Park Comprehensive Cancer Center, and the Icahn School of Medicine at Mount Sinai have found that BV actually consists of two subtypes—one of which significantly increases the risk of developing chlamydia infections. The findings were made in a population of young Black and Hispanic women, who are disproportionately affected by both BV and chlamydia, but are historically understudied. The study, one of the largest and most comprehensive of its kind, was published online today in the journal Cell.
While most known types of DNA damage are fixed by our cells’ in-house DNA repair mechanisms, some forms of DNA damage evade repair and can persist for many years, new research shows. This means that the damage has multiple chances to generate harmful mutations, which can lead to cancer.
Garvan researchers have uncovered how chronic hepatitis C infection leads to autoimmune disease, which opens new paths for treatments.
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time patients wait, according to a new paper published in the Journal of Clinical Oncology.
Persister cells arise as a result of cancer treatment and they are often responsible for tumour relapse.
A team of researchers at IRB Barcelona has identified inflammatory gene silencing as a distinctive feature of persister tumour cells, thereby paving the way for the development of new treatments.
The study has been published in the journal Cancer Research.